Use of intravenous immunoglobulins for prophylaxis or treatment of infectious diseases

被引：53

作者：

Hemming, VG ^{[1
]}

机构：

[1] Uniformed Serv Univ Hlth Sci, Off Dean, Bethesda, MD 20814 USA

来源：

CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY | 2001年 / 8卷 / 05期

关键词：

D O I：

10.1128/CDLI.8.5.859-863.2001

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：859 / 863

页数：5

共 46 条

[1]

*AM AC PED, 2000, 2000 RED BOOK REP CO

[2]

*AM AC PED, 2000, RED BOOK REP COMM IN, P42

[3]

AMER J, 1963, PEDIATRICS, V32, P4

[4] Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection [J].

Baba, TW ;

Liska, V ;

Hofmann-Lehmann, R ;

Vlasak, J ;

Xu, WD ;

Ayehunie, S ;

Cavacini, LA ;

Posner, MR ;

Katinger, H ;

Stiegler, G ;

Bernacky, BJ ;

Rizvi, TA ;

Schmidt, R ;

Hill, LR ;

Keeling, ME ;

Lu, YC ;

Wright, JE ;

Chou, TC ;

Ruprecht, RM .

NATURE MEDICINE, 2000, 6 (02) :200-206

[5] INTRAVENOUS IMMUNE GLOBULIN FOR THE PREVENTION OF NOSOCOMIAL INFECTION IN LOW-BIRTH-WEIGHT NEONATES [J].

BAKER, CJ ;

MELISH, ME ;

HALL, RT ;

CASTO, DT ;

VASAN, U ;

GIVNER, LB .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (04) :213-219

[6]

BRUTON OC, 1952, PEDIATRICS, V9, P722

[7] Chemical, clinical, and immunological studies on the products of human plasma fractionation. I. The characterization of the protein fractions of human plasma [J].

Cohn, EJ ;

Oncley, JL ;

Strong, LE ;

Hughes, WL ;

Armstrong, SH .

JOURNAL OF CLINICAL INVESTIGATION, 1944, 23 (04) :417-432

[8]

Condie R M, 1984, Birth Defects Orig Artic Ser, V20, P327

[9]

Connor E, 1997, PEDIATRICS, V99, P93

[10]

Cross AS, 1995, ADV EXP MED BIOL, V383, P123

← 1 2 3 4 5 →